Mehrzadi Saeed, Hosseini Pooyan, Mehrabani Mehrnaz, Siahpoosh Amir, Goudarzi Mehdi, Khalili Hamidreza, Malayeri Alireza
Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nutr Cancer. 2021;73(10):2039-2049. doi: 10.1080/01635581.2020.1820053. Epub 2020 Sep 16.
The present study aimed to investigate the protective effects of two potent natural antioxidants, gallic acid and quercetin as single or combination treatment against bleomycin-induced pulmonary fibrosis (PF). A total of 50 Wistar rats were randomly divided into 5 groups. Group 1 and 2 intratracheally received saline and bleomycin (7.5 UI/kg), respectively, on day 7, accompanied by oral saline administration for 28 day. Groups 3, 4, and 5 received a single dose of bleomycin on day 7, accompanied by oral administration of gallic acid, quercetin, and their combination, respectively, for 28 day. Finally, the lungs were removed for biochemical and histopathological tests. The combination treatment demonstrated a remarkable decrease in lung hydroxyproline and TNF- level and increase in catalase activity as compared with both single phytochemical-treated groups. The combination treatment significantly enhanced lung SOD activity and GSH level and decreased NO and IL-6 levels as compared with quercetin-treated group. However, only combination treatment could decrease the lung index and completely reversed histopathological changes in the bleomycin-treated group. In sum, when compared to a single exposure, the combination treatment might be a more effective approach for PF treatment because of its superior efficacy in reversing lung histological changes in the bleomycin-treated group.
本研究旨在探讨两种强效天然抗氧化剂没食子酸和槲皮素单独或联合治疗对博来霉素诱导的肺纤维化(PF)的保护作用。总共50只Wistar大鼠被随机分为5组。第1组和第2组分别在第7天经气管内给予生理盐水和博来霉素(7.5 UI/kg),并口服生理盐水28天。第3、4和5组在第7天接受单次博来霉素剂量,同时分别口服没食子酸、槲皮素及其组合,持续28天。最后,取出肺组织进行生化和组织病理学检测。与两个单独植物化学物质治疗组相比,联合治疗显示肺羟脯氨酸和TNF水平显著降低,过氧化氢酶活性增加。与槲皮素治疗组相比,联合治疗显著提高了肺SOD活性和GSH水平,降低了NO和IL-6水平。然而,只有联合治疗能够降低肺指数,并完全逆转博来霉素治疗组的组织病理学变化。总之,与单次暴露相比,联合治疗可能是一种更有效的PF治疗方法,因为它在逆转博来霉素治疗组的肺组织学变化方面具有更高的疗效。